Bacterial DNA load in Staphylococcus aureus bacteremia is significantly higher in intravascular infections

PLoS One. 2022 Apr 20;17(4):e0266869. doi: 10.1371/journal.pone.0266869. eCollection 2022.

Abstract

Objectives: Determination of pathogen-specific bacterial DNA load (BDL) in blood has been shown to be directly correlated with severity of infection in patients with bacteremia. In the diagnostic work-up of patients with Staphylococcus aureus bacteremia (SAB), determination of the primary focus is imperative, because of implications for treatment duration, and ultimately prognosis. Here we investigate whether measurement of BDL in patients with SAB can distinguish between intravascular and extravascular foci of infection.

Methods: In a consecutive cohort of 43 patients with positive blood cultures with Staphylococcus aureus, we performed a quantitative PCR on whole blood to detect the bacterial DNA load. Infections were classified into 3 categories: i) soft tissue infections and phlebitis, ii) deep-seated infections and iii) endocarditis and other intravascular infections. Bacterial DNA loads and inflammatory parameters in the three categories were analyzed and compared.

Results: Median BDL in patients with endocarditis and other intravascular infections was 1015 cfu/ml, significantly higher than BDL in the other two categories (28 and 31 cfu/ml respectively). In contrast, CRP and leukocytes were not significantly different between the three patient categories. BDL could be detected in all patients with intravascular causes and levels were generally 10-30 times higher than in the other infection categories. Median BDL in non-survivors was 85 cfu/ml, which was higher than in survivors with a median BDL of 29 cfu/ml, although not significant.

Conclusions: In Staphylococcus aureus bacteremia pathogen-specific BDL is distinctly higher in patients with intravascular infections compared to extravascular origins. As measurement of BDL by PCR can easily be implemented in routine diagnostics, it can improve the diagnostic work-up of SAB by rapidly identifying the subset of patients who need higher dosages of antibiotics and additional measures to improve outcome.

MeSH terms

  • Bacteremia* / diagnosis
  • Bacteremia* / microbiology
  • DNA, Bacterial / genetics
  • Endocarditis*
  • Humans
  • Real-Time Polymerase Chain Reaction
  • Staphylococcal Infections* / microbiology
  • Staphylococcus aureus / genetics

Substances

  • DNA, Bacterial

Grants and funding

The authors received no specific funding for this work.